Date published: 2025-10-29

1-800-457-3801

SCBT Portrait Logo
Seach Input

CYP4A11 Inhibitors

Chemical inhibitors of CYP4A11 can function through a variety of mechanisms to inhibit the enzyme's activity. 17-Octadecynoic acid, for instance, acts as a mechanism-based inhibitor that binds covalently to the active site of CYP4A11, leading to its functional inhibition. This covalent binding ensures that the inhibitor is not readily displaced, thereby providing sustained inhibition of enzyme activity. Similarly, DDMS, a 1-aminobenzotriazole derivative, forms a metabolic intermediate complex with the enzyme, resulting in the inactivation of its essential heme group and subsequent inhibition of CYP4A11's catalytic function. Another potent inhibitor, HET0016, competes with the natural substrates of CYP4A11 by binding to the active site, thus directly blocking the metabolism of arachidonic acid into 20-HETE, a product of CYP4A11-mediated fatty acid metabolism. Azole compounds like Miconazole, Ketoconazole, Clotrimazole, Sulconazole, Tioconazole, and Econazole exert their inhibitory effects on CYP4A11 by binding to the heme component of the enzyme. This interaction impairs the enzyme's electron transfer capabilities, which are crucial for the oxidative metabolism of fatty acids, thus effectively inhibiting CYP4A11 activity. Each of these chemicals demonstrates a specific action on CYP4A11, either through covalent modification, competitive inhibition, or interaction with the heme group, leading to a decrease in the enzyme's ability to process its substrates.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

17-ODYA (17-Octadecynoic acid)

34450-18-5sc-200488
sc-200488C
sc-200488A
sc-200488B
1 mg
5 mg
10 mg
100 mg
$42.00
$132.00
$214.00
$1438.00
9
(1)

This fatty acid acts as a mechanism-based inhibitor of CYP4A11 by binding covalently to the active site of the enzyme, leading to its functional inhibition.

DDMS

206052-03-1sc-205289
sc-205289A
1 mg
5 mg
$112.00
$510.00
(0)

1-Aminobenzotriazole derivative, DDMS, specifically inhibits CYP4A11 by forming a metabolic intermediate complex that inactivates the heme group essential for the enzyme's activity.

HET-0016

339068-25-6sc-200673B
sc-200673
sc-200673D
sc-200673A
sc-200673C
1 mg
5 mg
10 mg
25 mg
100 mg
$24.00
$99.00
$147.00
$388.00
$1102.00
5
(1)

As a selective inhibitor of 20-HETE synthesis, HET0016 directly inhibits CYP4A11 by competitively binding to its active site, preventing the enzyme from metabolizing arachidonic acid.

Miconazole

22916-47-8sc-204806
sc-204806A
1 g
5 g
$65.00
$157.00
2
(1)

As an imidazole antifungal agent, Miconazole inhibits CYP4A11 by binding to the heme component of the enzyme, thereby inhibiting its catalytic activity.

Ketoconazole

65277-42-1sc-200496
sc-200496A
50 mg
500 mg
$62.00
$260.00
21
(1)

Ketoconazole is known to inhibit CYP4A11 by interacting with its heme iron, which is essential for the enzyme's metabolism of fatty acids.

Clotrimazole

23593-75-1sc-3583
sc-3583A
100 mg
1 g
$41.00
$56.00
6
(2)

Clotrimazole inhibits CYP4A11 by binding to its heme iron, similar to other azole inhibitors, leading to a decrease in enzyme activity.

Sulconazole

61318-90-9sc-338599
100 mg
$1000.00
1
(0)

This compound inhibits CYP4A11 by binding to the heme group, similar to other azole derivatives, preventing the metabolism of the enzyme's natural substrates.

Tioconazole

65899-73-2sc-205864
sc-205864A
1 g
5 g
$75.00
$118.00
1
(0)

Tioconazole inhibits CYP4A11 by interacting with its heme group, thus inhibiting the enzyme′s activity.

Econazole

27220-47-9sc-279013
5 g
$240.00
(0)

Econazole acts as an inhibitor of CYP4A11 by binding to the enzyme's heme iron, which is necessary for its catalytic function.

6-[4-(1H-imidazol-1-yl)phenoxy]-N,N-dimethyl-1-hexanamine, dihydrochloride

502656-68-0sc-205155
sc-205155A
1 mg
5 mg
$38.00
$172.00
(0)

6-[4-(1H-imidazol-1-yl)phenoxy]-N,N-dimethyl-1-hexanamine, dihydrochloride exhibits distinctive interactions with CYP4A11, characterized by its imidazole moiety that facilitates coordination with heme iron. This compound's unique structural features promote specific electrostatic interactions, enhancing substrate binding. Its reaction kinetics suggest a rapid turnover rate, influenced by conformational flexibility, which may modulate enzyme activity and substrate specificity in metabolic pathways.